355 related articles for article (PubMed ID: 15042675)
1. Metastatic trophoblastic disease after an initial diagnosis of partial hydatidiform mole: genotyping and chromosome in situ hybridization analysis.
Cheung AN; Khoo US; Lai CY; Chan KY; Xue WC; Cheng DK; Chiu PM; Tsao SW; Ngan HY
Cancer; 2004 Apr; 100(7):1411-7. PubMed ID: 15042675
[TBL] [Abstract][Full Text] [Related]
2. Complete hydatidiform mole with retained maternal chromosomes 6 and 11.
McConnell TG; Norris-Kirby A; Hagenkord JM; Ronnett BM; Murphy KM
Am J Surg Pathol; 2009 Sep; 33(9):1409-15. PubMed ID: 19542869
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and subclassification of hydatidiform moles using p57 immunohistochemistry and molecular genotyping: validation and prospective analysis in routine and consultation practice settings with development of an algorithmic approach.
McConnell TG; Murphy KM; Hafez M; Vang R; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):805-17. PubMed ID: 19145201
[TBL] [Abstract][Full Text] [Related]
4. Characterization of androgenetic/biparental mosaic/chimeric conceptions, including those with a molar component: morphology, p57 immnohistochemistry, molecular genotyping, and risk of persistent gestational trophoblastic disease.
Lewis GH; DeScipio C; Murphy KM; Haley L; Beierl K; Mosier S; Tandy S; Cohen DS; Lytwyn A; Elit L; Vang R; Ronnett BM
Int J Gynecol Pathol; 2013 Mar; 32(2):199-214. PubMed ID: 23370656
[TBL] [Abstract][Full Text] [Related]
5. Analysis of gestational trophoblastic disease by genotyping and chromosome in situ hybridization.
Lai CY; Chan KY; Khoo US; Ngan HY; Xue WC; Chiu PM; Tsao SW; Cheung AN
Mod Pathol; 2004 Jan; 17(1):40-8. PubMed ID: 14631372
[TBL] [Abstract][Full Text] [Related]
6. The usefulness of p57(KIP2) immunohistochemical staining and genotyping test in the diagnosis of the hydatidiform mole.
Landolsi H; Missaoui N; Brahem S; Hmissa S; Gribaa M; Yacoubi MT
Pathol Res Pract; 2011 Aug; 207(8):498-504. PubMed ID: 21767919
[TBL] [Abstract][Full Text] [Related]
7. Hydatidiform moles: ancillary techniques to refine diagnosis.
Ronnett BM; DeScipio C; Murphy KM
Int J Gynecol Pathol; 2011 Mar; 30(2):101-16. PubMed ID: 21293291
[TBL] [Abstract][Full Text] [Related]
8. A clinico-pathological study of complete and partial hydatidiform moles in a Nigerian population.
Osamor JO; Oluwasola AO; Adewole IF
J Obstet Gynaecol; 2002 Jul; 22(4):423-5. PubMed ID: 12521470
[TBL] [Abstract][Full Text] [Related]
9. Morphological, immunohistochemical and chromosome in situ hybridization in the differential diagnosis of Hydatidiform Mole and Hydropic Abortion.
Maggiori MS; Peres LC
Eur J Obstet Gynecol Reprod Biol; 2007 Dec; 135(2):170-6. PubMed ID: 17602823
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the chromosomal region 19q13.4 in two Chinese families with recurrent hydatidiform mole.
Zhao J; Moss J; Sebire NJ; Cui QC; Seckl MJ; Xiang Y; Fisher RA
Hum Reprod; 2006 Feb; 21(2):536-41. PubMed ID: 16239310
[TBL] [Abstract][Full Text] [Related]
11. Diploid hydatidiform moles with fetal red blood cells in molar villi. 2--Genetics.
Fisher RA; Paradinas FJ; Soteriou BA; Foskett M; Newlands ES
J Pathol; 1997 Feb; 181(2):189-95. PubMed ID: 9120724
[TBL] [Abstract][Full Text] [Related]
12. Morphology and DNA content analysis in the evaluation of first trimester placentas for partial hydatidiform mole (PHM).
Chew SH; Perlman EJ; Williams R; Kurman RJ; Ronnett BM
Hum Pathol; 2000 Aug; 31(8):914-24. PubMed ID: 10987251
[TBL] [Abstract][Full Text] [Related]
13. Tetraploid partial hydatidiform mole: a case report and review of the literature.
Murphy KM; Descipio C; Wagenfuehr J; Tandy S; Mabray J; Beierl K; Micetich K; Libby AL; Ronnett BM
Int J Gynecol Pathol; 2012 Jan; 31(1):73-9. PubMed ID: 22123726
[TBL] [Abstract][Full Text] [Related]
14. [Epidemiologic and clinicopathologic studies of partial hydatidiform mole].
Kodama A; Kanazawa K; Honma S; Aoki Y; Tanaka K; Takahashi H
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Sep; 43(9):1219-25. PubMed ID: 1919183
[TBL] [Abstract][Full Text] [Related]
15. The risk of persistent trophoblastic disease after hydatidiform mole classified by morphology and ploidy.
Niemann I; Hansen ES; Sunde L
Gynecol Oncol; 2007 Feb; 104(2):411-5. PubMed ID: 17011616
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of selective molecular genotyping for diagnosis of partial hydatidiform mole; a retrospective study from a regional trophoblastic disease unit.
Fisher RA; Tommasi A; Short D; Kaur B; Seckl MJ; Sebire NJ
J Clin Pathol; 2014 Nov; 67(11):980-4. PubMed ID: 25078332
[TBL] [Abstract][Full Text] [Related]
17. Villous cytotrophoblast proliferating potential in complete and partial hydatidiform mole: diagnostic value of silver-stained nucleolar organizer region (AgNOR)-associated proteins.
Neudeck H; Unger M; Hufnagl P; Eiben B; Peters K; Kalla J; Graf R; Vogel M
Gen Diagn Pathol; 1997 Nov; 143(2-3):179-84. PubMed ID: 9443574
[TBL] [Abstract][Full Text] [Related]
18. The risk of post-molar gestational trophoblastic neoplasia is higher in heterozygous than in homozygous complete hydatidiform moles.
Baasanjav B; Usui H; Kihara M; Kaku H; Nakada E; Tate S; Mitsuhashi A; Matsui H; Shozu M
Hum Reprod; 2010 May; 25(5):1183-91. PubMed ID: 20208060
[TBL] [Abstract][Full Text] [Related]
19. Diandric triploid hydatidiform mole with loss of maternal chromosome 11.
DeScipio C; Haley L; Beierl K; Pandit AP; Murphy KM; Ronnett BM
Am J Surg Pathol; 2011 Oct; 35(10):1586-91. PubMed ID: 21881485
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the role of histopathology and DNA image analysis in the diagnosis of molar and non-molar abortion: a study of 89 cases in the center of Tunisia.
Landolsi H; Missaoui N; Yacoubi MT; Trabelsi A; Rammeh-Rommani S; Hidar S; Gribaa M; Hmissa S; Mokni M
Pathol Res Pract; 2009; 205(11):789-96. PubMed ID: 19665315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
